APROGEN
Aprogen is a unique biotechnology venture. Based on long-term basic scientific research results, Aprogen has accumulated unique and innovative protein drug development technologies. They have developed the antibody biosimilars for the first time in Korea and have been transferred to other companies. Since then, they have been developing protein and antibody drug design technology, high efficiency cell line manufacturing technology for antibody drug production, mass production technology of antib... ody drug using bioreactor , Drug efficacy, and pharmacological characterization technology, they now have unparalleled technology and R & D infrastructure to compete with major overseas pharmaceutical companies. Aprogen's bio business strategy is to develop innovative biopharmaceuticals based on global technological competitiveness and to develop biosimilars products with high clinical effectiveness as long-term proven and marketable biosimilars as blockbuster biopharmaceuticals.
APROGEN
Industry:
Biotechnology
Founded:
2000-01-01
Address:
Seongnam, Kyonggi-do, South Korea
Country:
South Korea
Website Url:
http://www.aprogen.com
Total Employee:
11+
Status:
Active
Contact:
031-625-4045
Total Funding:
20 B KRW
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apache Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS JQuery CDN
Current Employees Featured
Founder
Investors List
Lindeman Asia Global Pioneer
Lindeman Asia Global Pioneer investment in Venture Round - Aprogen
Official Site Inspections
http://www.aprogen.com Semrush global rank: 3.7 M Semrush visits lastest month: 3.74 K
- Host name: 123.141.228.75
- IP address: 123.141.228.75
- Location: Seongnam-si South Korea
- Latitude: 37.4388
- Longitude: 127.1396
- Timezone: Asia/Seoul
- Postal: 13332
More informations about "Aprogen"
Organization - APROGEN
Aprogen is a biopharmaceutical company that develops medicines that can reach and be readily available to the people in need and for the benefit of the general health. APROGEN - โฆSee details»
About Us - APROGEN
Aprogen is a biopharmaceutical company that develops medicines that can reach and be readily available to the people in need and for the benefit of the general health. APROGEN - About Us About UsSee details»
APROGEN
Aprogen is a biopharmaceutical company that develops medicines that can reach and be readily available to the people in need and for the benefit of the general health.See details»
Aprogen Pharmaceuticals - Crunchbase Company Profile & Funding
Headquarters Regions Asia-Pacific (APAC); Founded Date Dec 1960; Operating Status Active; Last Funding Type Venture - Series Unknown; Also Known As Gunpoong Industrial co ltd, โฆSee details»
Aprogen - LinkedIn
Aprogen | 435 followers on LinkedIn. Biopharmaceutical company focused on developing and manufacturing biosimilar products, new protein drugs and bispecific antibodiesSee details»
Aprogen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Aprogen, Inc. engages in the manufacture, maintenance, and repair of heavy and chemical plant facilities. It operates through the following business divisions: Hardfacing, Metal, Nukon โฆSee details»
Aprogen Company Profile 2024: Stock Performance
Aprogen General Information Description. Manufacturer of biosimilar pharmaceutical products based in Seongnam-si, South Korea. The company develops protein and antibody drug design and cell line production technology โฆSee details»
Aprogen Company Profile - Office Locations, Competitors ... - Craft
Aprogen is a biologics platform company focused on developing and manufacturing biosimilar products, protein drugs, and bispecific antibodies. It develops various recombinant antibody โฆSee details»
Novel Drugs - APROGEN
Aprogen. 545, Dunchon-daero, Jungwon-gu, Seongnam-si, Gyeonggi-do, Republic of Korea, 13215. Contact : +82-31-625-4045See details»
APROGEN - History
04 Established Aprogen Biologics Inc. for constructing Osong Plant 02 Contracted global license rights for GS071 with Nichi-Iko Pharmaceuticals Co., Ltd. 2012 11 Relocated headquarters to โฆSee details»
Aprogen, Inc. - BIO International Convention | BIO
Jun 5, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... We, โฆSee details»
Aprogen, 1st Korean biotech firm to win unicorn status
Dec 11, 2019 Aprogen has joined the list of unicorn companies, as the first Korean biotech firm. CB Insights, a U.S. market research firm, gave the unicorn status to Aprogen on Monday. A โฆSee details»
APROGEN - What We Value
A person who is unafraid of change and failure to explore novel ideas and bring vitality to the organization. ... Aprogen. 545, Dunchon-daero, Jungwon-gu, Seongnam-si, Gyeonggi-do, โฆSee details»
Aprogen - Crunchbase Company Profile & Funding
Aprogen is located in Seongnam, Kyonggi-do, South Korea. Who are Aprogen 's competitors? Alternatives and possible competitors to Aprogen may include Nagashima Engineering , CXR , โฆSee details»
APROGEN - Leadership
Aprogen is a biopharmaceutical company that develops medicines that can reach and be readily available to the people in need and for the benefit of the general health.See details»
APROGEN - R&D Center
A Cell Line is critical in determining a biological drug's quality, safety, and productivity. Cell Line Development bridges the gap from research to production, serves as a starting point of all โฆSee details»
Aprogen - Overview, News & Similar companies | ZoomInfo.com
Who is Aprogen. For this purpose, Aprogen KIC will advance to make the 'Value Creation Management' that take active actions for the rapidly changing economic envir onment through โฆSee details»
APROGEN - Aprogen Group
Aprogen Biologics. Novel Biologics / Biosimilars Production. Chemical Drug Production / Biologics Distribution. Aprogen H&G. Chemical Drug Distribution, Game Publishing. AGT. Innovative โฆSee details»
iProgen
Welcome to iProgen, a trailblazing biotech company based in Vancouver, Canada. Weโre at the forefront of next-generation antibody drug conjugate discovery, thanks to our innovative, in โฆSee details»
APROGEN - Osong Plant
No. of Employees 379; Constructed on Apr. 2018; Ground Area 42,318.3ใก; Floor Area 52,247ใก; 1 Annual API Production Capacity โฅ 3,000 kg. 2 Comparable to the capacity of 300,000L fed โฆSee details»